Effect of 5alpha Reductase Inhibitor Dutasteride on the Prevention of the Prostate Cancer in Men With High Grade Intraepithelial Neoplasia of the Prostate
Phase of Trial: Phase III
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer; Prostatic intraepithelial neoplasia
- Focus Therapeutic Use
- 04 Mar 2018 Status changed from recruiting to completed.
- 15 Apr 2014 Results presented at the 29th Congress of the European Association of Urology.
- 15 Nov 2008 New trial record.